NCOVTEST.co.uk is a newly formed initiative to help medical professionals, businesses and institutions to test their workforces for COVID-19 using IgG/IgM Rapid Test Kits and Antibody presence serology tests.
All tests supplied are accompanied by the following documentation:
CE marked and registered for professional use under european and CE-IVD regulation.
Documentation of EC Declaration & EC Conformity Certification.
External Clinical Study Report.
Test Kit manufacturer’s technical information or Instructions for Use (IFU)
You must be a professional institution or business in order to purchase test kits.
Sugentech® COVID-19 IgG/IgM Rapid Cassete Test (FDA/CE IVDk-MFSD)
For Frontline Healthcare Institutions
SGTi-flex COVID-19 IgM/IgG is a gold nanoparticle-based immunochromatographic test kit for qualitative determination of COVID-19’s IgM and IgG antibodies in human whole blood (finger prick or venous), serum or plasma. The kits are accurate and easy to use and results can be observed with the naked eye within 10 minutes.
The test detects the presence of antibodies, which are specific proteins made in response to infections. Antibodies can be found in the blood of those who are tested after infection. The antibodies detected by this test indicate that a person had an immune response to COVID-19, whether symptoms developed from infection or the infection was asymptomatic. Antibody test results are important in detecting infections with few or no symptoms.
As there is no medicine or vaccine, the best way to combat this infection is isolation. A lot of people don’t have symptoms. Because of that, quick diagnostics are very important. SGTi-flex COVID-19 IgM/IgG enables to help for community to identify infection and isolate people without symptoms but suspected COVID-19.
– US FDA listing No. D383895
– Korea MFDS Product-license No. 20-213
The test is a lateral flow immunoassay test and operates in a similar way to a pregnancy test. Embedded into the test strip are antibodies that bind to a COVID-19 specific biomarker, Immunoglobulin G (IgG), and another infection biomarker, Immunoglobulin M (IgM). When a sample (blood, serum or plasma) is added to one end of the test, it flows along the test strip and interacts with these antibodies. If the patient has contracted COVID-19, the biomarkers in their blood will bind to the antibodies on the test strip, leaving a visible test line. If the patient doesn’t have COVID-19, no biomarkers should be present in their blood and no test line will be visible. There are separate test lines for IgG and IgM and only one needs to be visible for a positive result.
Immunoglobulins are antibodies themselves and are part of our immune system. When we get an infection, such as COVID-19, immunoglobulins are produced, which attach to the virus and activate the rest of the immune system to attack and clear the virus. IgM is the first immunoglobulin to be produced and is a general antibody that can bind to many different types of pathogen. The presence of IgM is an indicator of early infection. IgG is a more specialised antibody that specifically binds to the SARS-CoV-2 virus. The presence of IgG is an indicator of later stage infection (usually 7 days or longer after infection).
The IgG that the test detects is specific to COVID-19, so a positive result would indicate COVID-19 infection. Although the IgM is a more generalised antibody, its presence, combined with IgG and/or the common symptoms of COVID-19, would also indicate infection with the novel SARS-CoV-2 virus. The test can be used for primary and secondary diagnosis of COVID-19.
The test cassette will work with whole blood, plasma or serum. Capillary blood is the easiest to obtain via a finger pinprick, however, venous blood obtained via venepuncture is also suitable. The type of sample will not affect the sensitivity or accuracy of the test.
The buffer solution has two functions. It acts as the carrier for the sample, allowing it to laterally flow along the test strip, and it maintains a constant sample pH as it flows, preventing degradation of the biomarkers and the antibodies. We recommend that you only use the buffer solution provided with the test kits, as other ones may affect the accuracy of the test.
We are an aggregator of COVID-19 testing solutions for Professional use only. COVID-19 rapid tests identifies the body’s response to coronavirus during the onset of infection, and gives a qualitative yes/no result within 10 minutes.
Implementing rapid screening for COVID-19 has huge time and cost savings when compared to laboratory screening, and will help to control the spread of the virus by identifying infection rapidly and accurately.
The test cassette is easy to use, needing only a finger-prick sample to function, much like a blood glucose test.
Benefits Of The COVID-19 Rapid Test Cassette Kits
- Significant time and cost saving over lab methods
- Results within 10 minutes
- Identifies infection even in mild or asymptomatic cases
- Assists in the control of viral transmission
- Screen anywhere and everywhere
- Ideal as a triage and screening tool
- Accuracy of all tests available >95% (IgM) and >98% (IgG)
Supporting the national fight back against COVID-19
CE-marked for professional use, with use across Private Clinics in London, Care Homes and Primary Care.
Delivering 24/7, around the clock with dedicated drivers to support the Frontline.
Your support can help the fight against Covid-19. Below we have listed the Amazon Wish Lists of NHS Institutions and Care Homes across the UK. If you would like to provide support, simply purchase an item from the list below and it will be sent to them